10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $316,342 | -9.6% | 5,653 | -33.4% | 0.23% | -15.2% |
| Q3 2023 | $350,089 | -41.9% | 8,487 | -21.4% | 0.27% | -32.1% |
| Q2 2023 | $602,960 | +4.3% | 10,798 | +4.2% | 0.40% | -2.2% |
| Q1 2023 | $578,096 | +48.2% | 10,362 | -3.2% | 0.40% | +25.0% |
| Q4 2022 | $390,000 | +39.3% | 10,707 | +9.1% | 0.32% | +36.7% |
| Q3 2022 | $280,000 | -46.2% | 9,817 | -14.6% | 0.24% | +99.2% |
| Q2 2022 | $520,000 | -14.6% | 11,493 | +43.6% | 0.12% | -71.0% |
| Q1 2022 | $609,000 | -41.2% | 8,001 | +15.1% | 0.41% | -41.3% |
| Q4 2021 | $1,036,000 | +13.2% | 6,952 | +10.6% | 0.70% | +10.8% |
| Q3 2021 | $915,000 | -13.8% | 6,288 | +15.9% | 0.63% | -12.6% |
| Q2 2021 | $1,062,000 | +305.3% | 5,425 | +274.7% | 0.72% | +179.2% |
| Q1 2021 | $262,000 | – | 1,448 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |